new glp 1 receptor agonists GLP-1 as Treatments for Type 2 Diabetes Possible mechanisms of action of

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

What does the Gila monster have that we dont have

Mattioli Introduction GLP-1 agonists like liraglutide have become a powerful tool for weight management, but they often come with digestive side effects and concerns about long-term use

Find pharmacy-related safety alerts, drug recall and new generic drug announcements and other medication information for healthcare providers.